The global High Pressure Contrast Media Injectors Market size is expected to reach USD 362.8 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 12.1% from 2021 to 2028. The market is primarily driven by the factors such as the increasing number of target diseases, such as cardiovascular diseases, neurovascular, and cancer also the rising demand for minimally invasive surgical procedures is a major factor expected to boost the market during the forecast period.
Technological advances have contributed to the expansion
of the market. For instance, several advancements in contrast media injector
technology have been made to reduce contrast media waste and automate data
collection about the dose a patient receives. Automated injector systems, for
example, precisely gather the amount of contrast media used, and companies have
begun to offer personalized doses for patients based on data from EMR or PACS.
Syringeless injectors are one such advancement in lowering contrast media
waste.
The increasing prevalence of cardiovascular diseases,
cancer, orthopedic cases, gastrointestinal diseases, and vascular diseases
globally is anticipated to boost the demand for contrast injectors, as they are
the most common clinical applications for contrast-enhanced imaging systems. As
a result of major companies' continued R&D spending and efforts to launch
their products at a low cost, Asia Pacific is predicted to have the fastest
CAGR from 2021 to 2028. In addition, the medical tourism business in
the region is rapidly developing. The regional market will be boosted even
higher by expanding healthcare infrastructure and increased per capita
spending.
Related Press
Release@ High
Pressure Contrast Media Injectors Market Report
High Pressure Contrast Media Injectors Market Report
Highlights
- The
consumable segment was the largest revenue-generating segment in 2020
owing to its benefits such as user-friendly, high efficiency, and minimal
contrast media wastage
- The
single head injectors segment accounted for the largest revenue share in
2020, whereas the dual-head injector segment is expected to grow at a
significant rate during the forecast period
- The
interventional cardiology segment held the largest revenue share in 2020
because of the rising prevalence of cardiac diseases, such as coronary
artery disease, heart valve disease, and peripheral vascular disease
- In
2020, North America dominated the market owing to the growing prevalence
of chronic diseases and the presence of highly advanced medical
infrastructure
- In
Asia Pacific, the market is anticipated to witness significant growth over
the forecast period owing to improving healthcare systems, rising
healthcare expenditure, and growing awareness
About Us:
Grand View Research, Inc. is a U.S. based market research
and consulting company, registered in the State of California and headquartered
in San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, the company offers market intelligence studies ensuring
relevant and fact-based research across a range of industries including
technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: https://www.grandviewresearch.com
No comments:
Post a Comment